Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compliant Glass Mechanism Instrumented with a Bragg Grating to Measure Indentation Force.

Micromachines·2026
Same author

A Novel Method for Cardiac Output and Vascular Parameters Estimation Using Peripheral Arterial Waveforms: Integrating Windkessel Model via <math><mrow><mi>α</mi></mrow></math> -parameter identification.

Annals of biomedical engineering·2026
Same author

Estimating V̇O<sub>2</sub> max in healthy subjects without maximal effort: a novel protocol using ballistocardiography.

Frontiers in sports and active living·2026
Same author

Detecting faulty lithium-ion cells in large-scale parallel battery packs using current distributions.

Communications engineering·2026
Same author

How spatial temperature gradients modulate infrared stimulation of the ex vivo rat sciatic nerve.

Biophysical journal·2025
Same author

A comprehensive analytical model for predicting drug absorption in the olfactory region: Application to nose-to-brain delivery.

International journal of pharmaceutics·2025

Related Experiment Video

Updated: Jul 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Unveiling the sumatriptan dose-relief relationship.

Clément Rigaut1, Benoit Haut2, Pierre Lambert2

  • 1TIPs (Transfers, Interfaces and Processes), Université libre de Bruxelles, Brussels, Belgium. clement.rigaut@ulb.be.

European Journal of Clinical Pharmacology
|July 15, 2026
PubMed
Summary

Sumatriptan brain concentration directly correlates with patient pain relief. This study establishes a dose-effect relationship for sumatriptan, aiding in predicting treatment outcomes across various administration routes.

Keywords:
ConcentrationMigrainePharmacokineticsResponseTriptan

Related Experiment Videos

Last Updated: Jul 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacology
  • Migraine Treatment

Background:

  • Sumatriptan is a widely used medication for acute migraine attacks.
  • Understanding the relationship between sumatriptan pharmacokinetics and clinical efficacy is crucial for optimizing treatment.
  • Previous studies have explored sumatriptan's effects, but a direct correlation with pharmacokinetic parameters and patient-reported relief is needed.

Purpose of the Study:

  • To correlate the pharmacokinetic parameters of sumatriptan with the percentage of patients achieving pain relief at two hours post-administration.
  • To establish a predictive model for sumatriptan's clinical effect based on its concentration in the brain.

Main Methods:

  • Development of a two-compartment pharmacokinetic model using existing literature data.
  • Computation of sumatriptan concentration in the brain for diverse administration routes and dosages.
  • Correlation of calculated brain concentrations with reported clinical effects (pain relief).

Main Results:

  • A linear correlation was identified between the maximum sumatriptan concentration in the brain and the percentage of patients experiencing pain relief within two hours.
  • The model allows prediction of the drug's action time based on the temporal profile of brain concentration for various dose-route combinations.

Conclusions:

  • The established correlation provides a clear link between sumatriptan dosage, administration route, and therapeutic effect.
  • This pharmacokinetic-pharmacodynamic modeling approach can be extended to other drugs to investigate their dose-response relationships.